Search
for
Sort by
Research 331–360 of 1000+
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- A Case Report of Male Systemic Lupus Erythematous with Antinuclear Antibodies-Negative: A Challenging Diagnosis
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Management of Toxicities of Targeted Therapies
- Current and future pharmacotherapy for alopecia areata
- Inherited Disorders of the Hair
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia Areata
- Current systemic treatment strategies for hidradenitis suppurativa
- British Hair and Nail Society
- Antihelminthic Drugs
- Cutaneous drug reactions
- Docetaxel-induced Psoriasis
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Aesthetic medicine treatments for oncology patients — a narrative literature review
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Farmácia São Lázaro - Porto e nos Serviços Farmacêuticos do Hospital Privado de Vila Real (Grupo Trofa Saúde) - Vila Real
- Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Advances in dermatology research: A comprehensive literature review
- Journal of Population Therapeutics and Clinical Pharmacology